Consequently, TBK1 stands out as a pivotal element in the molecular pathway contributing to the inflammatory response in RA, presenting itself as a potential target for therapeutic strategies aimed at modulating immune-related mechanisms in this autoimmune disorder (39). Here, TBK1 is linked to autoimmune disease.